MRMD
Drug Manufacturers - Specialty & Generic · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Marimed Inc. publishes a filing, an earnings call transcript or a press release.
Get MRMD alertsThe proxy statement of Marimed Inc. reports total compensation of $347,687 for Ryan Crandall in fiscal 2025, including a base salary of $300,000. Ryan Crandall has spoken on 1 earnings call across 1 company, most recently for Marimed Inc. on November 12, 2026. Marimed Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Marimed Inc. includes Jon R. Levine (CEO and Board Member), Edward Gildea (Chairman), Mario Pinho (CFO) and 3 others.
“On last quarter's earnings call, I shared details about several strategies we implemented to grow revenue with a focus on expanding distribution, strengthening customer relationships, improving retail execution, and investing behind our top-selling brands.”
Proxy statement
Start not stated–present
Last confirmed April 23, 2026
MRMD
Drug Manufacturers - Specialty & Generic · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Marimed Inc. (MRMD) | Chief Commercial Officer | $300,000 | $347,687 |